Saturday

17th Apr 2021

EU Commission casts doubt on Russian Sputnik vaccine

  • The Financial Times reported Russia's Sputnik is currently being outsourced to private companies in Brazil, China, South Korea, India, and Iran (Photo: Wikimedia)

The European Commission has shed doubt on the Russian vaccine, Sputnik V.

European Commission president Ursula von der Leyen on Wednesday (17 February) posed questions on its use.

Read and decide

Join EUobserver today

Become an expert on Europe

Get instant access to all articles — and 20 years of archives. 14-day free trial.

... or subscribe as a group

  • 'We still wonder why Russia is offering theoretically millions of millions of doses while not sufficiently progressing in vaccinating their own people,' Ursula von der Leyen told reporters (Photo: European Union, 2021)

"We still wonder why Russia is offering theoretically millions of millions of doses while not sufficiently progressing in vaccinating their own people," she told reporters.

"This is also a question I think that should be answered," she added.

Neither the Russian vaccine nor its Chinese counterpart have so far reached out to the European Medicines Agency (EMA) for market authorisation.

Such a step is required for EU-wide use, which also ensures safety and liability guarantees should things go wrong.

"They have to submit the whole set of data, indeed go through the whole scrutiny process like any other vaccine," von der Leyen pointed out.

The Russian and Chinese vaccines are not being produced in Europe.

Because of that, von der Leyen said inspection on the production side also needs to be carried out to guarantee quality.

EU industrial commissioner Thierry Breton also weighed in.

"Manufacturing is another story, it is very complex, if you look at Sputnik," he said.

He noted that the vaccine requires two doses, rendering the manufacturing process more complex.

The Financial Times reported Russia's production of Sputnik is currently being outsourced to private companies all operating under different national regulations.

This includes factories in Brazil, China, South Korea, India, and Iran.

A large part of the production is outsourced to a plant in India, which is still awaiting approval from national regulators, according to the newspaper.

The peer-reviewed medical journal Lancet declared Sputnik earlier this month as safe and effective.

But EU health commissioner Stella Kyriakides said the Russian and Chinese vaccine still have to first undergo an EMA independent scientific assessment.

"This process allows for pharmacovigilance and it is something that we must never forget," she said.

The EU has so far approved three vaccines, with new additional ones likely in the near future.

Hungary rolls out Russian and Chinese jabs

But some EU states are still being enticed by the Russian and Chinese vaccines.

Governments in the EU are allowed to purchase the vaccines without EMA approval, if deemed urgent.

But doing so forgoes all the safety and liability issues covered by EU validated vaccines.

Among them is Hungary, which is rolling out both to its population.

This week, it gave the first batch of 2,800 Sputnik doses to elderly people. A large shipment from China has also arrived, which is set to inoculate 275,000 people.

"The issue of the vaccine should be depoliticised," said Hungary's prime minister Viktor Orban on Wednesday.

"For Hungary, speed is the most important thing," he said, adding that the vaccine must be obtained quickly and with the necessary safety checks.

But the move is still raising thorny questions given the production and regulatory pitfalls the vaccines face.

Some 33 million doses of the EU's approved vaccines have been delivered to people throughout the European Union, according to von der Leyen.

Tackling variants

The comments come as the European Commission on Wednesday unveiled its latest efforts to speed up the production of vaccines to tackle new variants.

It has described the variants as a potential paradigm shift in the global fight against Covid-19.

It will next week present its proposal to EU heads of state and government.

The plan includes pooling public-private cooperation along with scientists and regulators to detect and mass produce vaccines against any new variants.

It means tweaking already-approved vaccines at the EU level, setting up a European clinical trials network, and upscaling mass production of new vaccines.

It has also set aside some €75m to help detect new variants and €150m for research projects.

The EU has some 16 industrial sites capable of producing vaccines and other 15 companies able to bottle and finalise the roll outs.

"We need to insure that our continent can be fully autonomous when it comes to vaccine production," said Breton.

EU fraud agency warns governments on vaccine scams

OLAF said fraudsters may offer to sell large quantities of vaccines, deliver a sample in order to pocket the first advance payment - and then vanish with the money, or deliver fake vaccines.

EU targets vaccinating 70% of adults by summer

The European Commission has announced targets to accelerate the roll-out of vaccination, and the intention of "a common approach" on possible vaccine certificates. Both topics will be discussed by EU leaders on Thursday.

Von der Leyen concedes mistakes in vaccine rollout

The European Commission admitted mistakes were made during the bloc's approval and rollout of vaccines - triggering criticism from MEPs who demanded more transparency and accountability, plus solidarity with low and medium-income countries.

Worries on Europe's infection surge, after six-week drop

The World Health Organization warned of a surge in new coronavirus infections across Europe, pointing out healthcare systems should not be under pressure in some countries. Meanwhile, the European Medical Agency is reviewing Russia's Sputnik vaccine.

News in Brief

  1. EU postpones decision on labelling gas 'sustainable'
  2. MEPs call for mass surveillance ban in EU public spaces
  3. Greek and Turkish ministers trade jibes in Ankara
  4. Biden repeats opposition to Russia-Germany pipeline
  5. Navalny in danger, letter warns EU foreign ministers
  6. Lithuania keen to use Denmark's AstraZeneca vaccines
  7. Gas plants largest source of power-sector emissions
  8. Study: Higher risk of blood clots from Covid than vaccines

Stakeholders' Highlights

  1. Nordic Council of MinistersDigitalisation can help us pick up the green pace
  2. Nordic Council of MinistersCOVID19 is a wake-up call in the fight against antibiotic resistance
  3. Nordic Council of MinistersThe Nordic Region can and should play a leading role in Europe’s digital development
  4. Nordic Council of MinistersNordic Council to host EU webinars on energy, digitalisation and antibiotic resistance
  5. UNESDAEU Code of Conduct can showcase PPPs delivering healthier more sustainable society
  6. Nordic Council of MinistersWomen benefit in the digitalised labour market

Latest News

  1. US rejects Slovenia-linked plan to break up Bosnia
  2. Ukraine urges Borrell to visit Russia front line
  3. Could US sanctions hit Russia vaccine sales to EU?
  4. Polish court pushes out critical ombudsman
  5. Political crises in Romania and Bulgaria amid third wave
  6. Von der Leyen's summer plans undisclosed, after Ukraine snub
  7. Over a million EU citizens back farm-animal cage ban
  8. Three options for West on Putin's Ukraine build-up

Join EUobserver

Support quality EU news

Join us